Fate Therapeutics, Inc. (FATE)
NASDAQ·Healthcare·Biotechnology
$1.31
+0.00%
Mkt Cap $152.31M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (20 analysts)
$39.50
Range $3.00 – $145.00
Implied Upside
+2915.3%
Consensus $39.50 vs current $1.31
NASDAQ·Healthcare·Biotechnology
$1.31
+0.00%
Mkt Cap $152.31M
Buy
1
Hold
0
Sell
0
Price Target (20 analysts)
$39.50
Range $3.00 – $145.00
+2915.3%
Consensus $39.50 vs current $1.31